ERAXIS (Roerig)
Welcome to the PulseAid listing for the ERAXIS drug offered from Roerig. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Roerig |
NON-PROPRIETARY NAME: | anidulafungin |
SUBSTANCE NAME: | ANIDULAFUNGIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2006-02-17 |
END MARKETING DATE: | 0000-00-00 |
ERAXIS HUMAN PRESCRIPTION DRUG Details:
Item Description | ERAXIS from Roerig |
LABELER NAME: | Roerig |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/15mL) |
START MARKETING DATE: | 2006-02-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0049-0114_abc8d51a-7bc1-409a-8ae9-f4195cd14d54 |
PRODUCT NDC: | 0049-0114 |
APPLICATION NUMBER: | NDA021632 |
Other ANIDULAFUNGIN Pharmaceutical Manufacturers / Labelers: